BETA

IPO registrations (S-1, F-1) · Registrants

HTG MOLECULAR DIAGNOSTICS, INC

SEC CIK
1169987 · filings on EDGAR ↗
Former names
HTG MOLECULAR DIAGNOSTICS INC (2011–2012); HIGH THROUGHPUT GENOMICS INC (2002–2011)
Registration
Form S-1, first filed 2014-12-30, last 2022-12-21; 2 initial registrations, 3 amendments
Outcome
Final prospectus filed 2015-05-06; declared effective 2015-05-05
Industry (SIC)
Laboratory Analytical Instruments 3826
Incorporated in
DE
Business address
3430 E. GLOBAL LOOP, Tucson, AZ 85706
EIN
86-0912294
EDGAR entity type
operating
Insiders and CEO pay
HTG MOLECULAR DIAGNOSTICS, INC on the corporate pages

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 2015-04-28)
Final price
$14.00 per share, within the range (424B4 filed 2015-05-06, an initial public offering)
Shares sold
3,570,000
Gross proceeds
$49,980,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol HTGM
Lead underwriters
Leerink Partners
Syndicate
Canaccord Genuity; JMP Securities

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2014-12-30S-1S-1 (registration)HTG MOLECULAR DIAGNOSTICS, INC0001193125-14-457160 ↗
2015-02-25S-1/AS-1/A (amendment)HTG MOLECULAR DIAGNOSTICS, INC0001193125-15-062861 ↗
2015-04-28S-1/AS-1/A (amendment)HTG MOLECULAR DIAGNOSTICS, INC0001193125-15-150655 ↗
2015-05-05EFFECTEFFECT (declared effective)HTG MOLECULAR DIAGNOSTICS, INC9999999995-15-001222 ↗
2015-05-06424B4424B4 (final prospectus)HTG MOLECULAR DIAGNOSTICS, INC0001193125-15-174820 ↗
2017-04-06EFFECTEFFECT (declared effective)HTG MOLECULAR DIAGNOSTICS, INC9999999995-17-000755 ↗
2019-02-11EFFECTEFFECT (declared effective)HTG MOLECULAR DIAGNOSTICS, INC9999999995-19-000161 ↗
2019-11-26EFFECTEFFECT (declared effective)HTG MOLECULAR DIAGNOSTICS, INC9999999995-19-002672 ↗
2022-02-02EFFECTEFFECT (declared effective)HTG MOLECULAR DIAGNOSTICS, INC9999999995-22-000313 ↗
2022-04-19EFFECTEFFECT (declared effective)HTG MOLECULAR DIAGNOSTICS, INC9999999995-22-001032 ↗
2022-12-06S-1S-1 (registration)HTG MOLECULAR DIAGNOSTICS, INC0001193125-22-298835 ↗
2022-12-21S-1/AS-1/A (amendment)HTG MOLECULAR DIAGNOSTICS, INC0001193125-22-309498 ↗
2022-12-21EFFECTEFFECT (declared effective)HTG MOLECULAR DIAGNOSTICS, INC9999999995-22-003606 ↗
2022-12-22424B4424B4 (final prospectus)HTG MOLECULAR DIAGNOSTICS, INC0001193125-22-311164 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-04-28S-1/Aregistration statement$13.00–$15.003,570,000-Nasdaq HTGM3primary document; range, shares headline, cover names 3document ↗
2015-05-06424B4final prospectus$14.003,570,000$49,980,000Nasdaq HTGM3primary document; price sentence, shares headline, proceeds table, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Bisgaard PeterDirector12015
Fletcher Spaght Ventures II LPTenPercentOwner22015
FSV II-B LPTenPercentOwner22015
FSV II LPTenPercentOwner22015
George Harry A.Director122015–2021
George SimeonDirector12015
GLAXOSMITHKLINE PLCOther; TenPercentOwner42015–2017
Gordon Debra AOfficerSVP, Chief Legal Counsel; V.P. and Chief Legal Counsel202015–2018
Hoult MaryDirector12015
JOHNSON TIM BDirector; Director,OfficerCEO; Executive Chairman; President & CEO392015–2021
Lubniewski John LDirector,Officer; OfficerChief Business Officer; President & CEO; President & COO; SVP, Chief Business Officer492015–2022
McMeans Shaun DOfficerSVP, Finance & Admin. & CFO; VP, Finance & Admin. & CFO532015–2022
Merck Capital Ventures LLCTenPercentOwner22015
Novo A/STenPercentOwner42015–2017
Roche Patrick C.OfficerSVP Medical/Scientific Affairs; SVP Research & Development132015–2018
Senour Lawrence D.TenPercentOwner22015
Shuster LewisDirector42015–2017
GRIMM DONALD WDirector22015
LAFRANCE JAMES TDirector112015–2021
McCracken Lee R.Director112015–2022
HARDISON DON MDirector102016–2022
HANHAM ANNDirector92016–2022
QIAGEN NVTenPercentOwner22016–2017
GRIFFIN MICHELLE RENEEDirector62018–2022
Godlewski Laura LeeOfficerSVP Finance & Administration; VP Finance, Prin Acct Offr; VP of Accounting and Reporting142019–2022
LYTTON LAURENCE WTenPercentOwner22019–2020
Lawson ByronOfficerSVP/Chief Commercial Officer192020–2022
KIRITSY CHRISTOPHER PDirector32022
L5 Capital Inc.TenPercentOwner12022
Dubensky Thomas W.Director22022
Barat StephenOfficerSenior VP of Therapeutics32023

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2022-03-25HTG MOLECULAR DIAGNOSTICS, INCOther Health Care$20,884,736$7,499,99911
2019-10-01HTG MOLECULAR DIAGNOSTICS, INCOther Health Care$3,517,597$3,463,48021
2015-01-23HTG MOLECULAR DIAGNOSTICS, INCBiotechnology$18,023,596$0191
2014-09-03HTG MOLECULAR DIAGNOSTICS, INCBiotechnology$800,000$021
2014-02-13HTG MOLECULAR DIAGNOSTICS, INCBiotechnology$21,736,348$7,476,879151

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationHTG Molecular Diagnostics, Inc.AZState business registriesname and state
Business registrationHTG MOLECULAR DIAGNOSTICS, INC.AZState business registriesname and state
Business registrationHTG MOLECULAR DIANOSTICS, INC.AZState business registriesEIN (EXACT, as the state registration reports it)
Federal award recipientHTG MOLECULAR DIAGNOSTICS, INC.AZFederal spending (USAspending)name and state
Form D issuerHTG MOLECULAR DIAGNOSTICS, INCAZForm D private offeringsCIK (EXACT)
Lobbying clientHTG MOLECULAR DIAGNOSTICS, INC.AZFederal lobbying (LDA)name and state
Patent assigneeHTG Molecular Diagnostics, Inc.AZPatents (USPTO)name and state
SEC filerHTG MOLECULAR DIAGNOSTICS, INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerHTG MOLECULAR DIAGNOSTICS, INC.AZTrademarks (USPTO)name and state
Form 5500 plan sponsorHTG MOLECULAR DIAGNOSTICS, INC.EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Laboratory Analytical Instruments, AZ first:

More with this interest.

In other datasets, the same topic (Technology) in AZ:

Interests: Laboratory Analytical Instruments · Technology